Table 3.
n | Women in whom laxatives had failed to provide adequate relief (prucalopride 2 mg) | |
---|---|---|
Spontaneous complete bowel movements | 114 | 0.4 ± 0.18a |
Spontaneous bowel movements | 113 | 1.3 ± 0.27b |
Bowel movements (spontaneous/non-spontaneous) | 113 | 1.6 ± 0.27b |
Values are mean ± standard error.
The table summarizes the within-patient difference between the average number of (spontaneous) (complete) bowel movements in weeks with 7 days of prucalopride intake and the average number of (spontaneous) (complete) bowel movements in weeks with 2–5 missing treatment days. For example, the average weekly number of spontaneous complete bowel movements decreases by 0.4 if patients miss their prucalopride dose on 2–5 days per week.
ap < 0.05, bp < 0.0001 for comparison of adherence vs non-adherence.